Tissue Maturation is a crucial phase in the development of engineered tissues, wherein the created constructs evolve to exhibit characteristics akin to natural, mature tissues. This process involves the refinement of cellular organization, extracellular matrix composition, and functional properties to achieve optimal performance and integration within the host organism. During tissue maturation, cells within the construct undergo differentiation, adopting specialized functions relevant to the targeted tissue type. The extracellular matrix undergoes remodeling, with the deposition and alignment of structural proteins contributing to the biomechanical strength and integrity of the tissue. Factors such as nutrient supply, oxygenation, and mechanical cues play pivotal roles in guiding tissue maturation. Bioreactors and perfusion systems are often employed to simulate physiological conditions, providing a conducive environment for cells to mature and organize appropriately. Monitoring techniques, including imaging, histological analyses, and functional assessments, are crucial for evaluating the degree of tissue maturation. Successful tissue maturation is paramount for the clinical efficacy of engineered tissues, ensuring their seamless integration, functionality, and long-term stability within the host. Ongoing research in tissue engineering emphasizes strategies and technologies to enhance the maturation process, contributing to advancements in regenerative medicine and the development of more sophisticated tissue-engineered constructs.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States